摘要:
A system and method for clustered failover of storage appliances is provided. In the event of a failover of one storage appliance to a surviving storage appliance, the surviving storage appliance assumes the identity of the failed storage appliance. This assumption of the identifier is accomplished by initializing a Fibre Channel Host Bus Adapter on the surviving storage appliance with the NodeName and PortNames of the failed storage appliance.
摘要:
A technique enables efficient access to logical unit numbers (luns) or virtual disks (vdisks) stored on a storage system, such as a multi-protocol storage appliance. The technique allows a grouping of initiators by a “human friendly” logical name that is mapped to a lun or vdisk on the storage appliance. The initiators are clients operating in, e.g., a storage area network (SAN) environment that initiate requests for the vdisk using block-based access protocols, such as the Small Computer Systems Interface (SCSI) protocol encapsulated over TCP/IP (iSCSI) or over fibre channel (FCP). The technique enables access to the vdisk by all initiators that are members of the initiator group (igroup). An igroup is a logical named entity that is assigned to one or more addresses associated with one or more initiators. These addresses may comprise fibre channel (FC) world wide name (WWN) or iSCSI name identifiers (IDs). Therefore, rather than having to specify these IDs when desiring access to a vdisk, an initiator need only specify the human friendly name of the igroup.
摘要:
The present invention includes fully human, neutralizing, monoclonal antibodies against human Insulin-like Growth Factor Receptor-I (IGFR1). The antibodies are useful for treating or preventing cancer in a subject. Also included are methods of using and producing the antibodies of the invention.
摘要:
Isolated human monoclonal antibodies which bind to Anthrax protective antigen are disclosed. The human antibodies can be produced in a non-human transgenic animal, e.g., a transgenic mouse, capable of producing multiple isotypes of human monoclonal antibodies by undergoing V-D-J recombination and isotype switching. Also disclosed are derivatives of the human antibodies (e.g., bispecific antibodies and immunoconjugates), pharmaceutical compositions comprising the human antibodies, non-human transgenic animals and hybridomas which produce the human antibodies, and therapeutic and diagnostic methods for using the human antibodies.
摘要:
The present invention provides isolated monoclonal antibodies, particularly human monoclonal antibodies, that specifically bind to IRTA-5 with high affinity. Nucleic acid molecules encoding the antibodies of the invention, expression vectors, host cells and methods for expressing the antibodies of the invention are also provided. Immunoconjugates, bispecific molecules and pharmaceutical compositions comprising the antibodies of the invention are also provided. The invention also provides methods for detecting IRTA-5, as well as methods for treating various B cell malignancies, including non-Hodgkin's lymphoma.